2001
DOI: 10.1016/s1359-6446(01)01842-6
|View full text |Cite
|
Sign up to set email alerts
|

Chinese pharmaceutical companies: an emerging industry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2005
2005
2020
2020

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 0 publications
0
7
0
Order By: Relevance
“…The scientific base for Indian herbal medicines is lacking. [16,17,18] 2. China has been willing to actively export its medical system.…”
Section: N T E R N At I O N a L M A R K E T S C E N A R I O O F Tramentioning
confidence: 99%
“…The scientific base for Indian herbal medicines is lacking. [16,17,18] 2. China has been willing to actively export its medical system.…”
Section: N T E R N At I O N a L M A R K E T S C E N A R I O O F Tramentioning
confidence: 99%
“…Growing popularity of TCM can be evidenced by the rapid increase in number of licensed Chinese medicine providers in the United States. The Chinese government has pledged to create several export-oriented TCM giants in the coming years ( 6 ). Continuous efforts in promotion of the indigenous therapies by China have put TCM in a commendable position.…”
Section: Introductionmentioning
confidence: 99%
“…Subsidies and favorable policy measures should be designed and prioritized to strengthen the performance of effective innovators (Nemet, ). The following innovation resources have been identified (Chan et al, ): (1)State‐Owned Enterprises (SOEs) (White, ; Jiang et al, ; Nolan and Yeung, ; Wang et al, ). (2)High‐tech Small‐to‐Medium Enterprises (SMEs) (Jiang et al, ; Boutellier and Ullman, ; Wang et al, ). (3)Multinational Company and subsidiaries (MNCs) (Boutellier and Ullman, ; Ghauri and Rao, ; Han, ). (4)Contract Research/Manufacture Organizations (CRO/CMOs) (Lawrence, ; Singh, ; Boutellier and Ullman, ). (5)University Research Programs (URPs) (Boutellier and Ullman, ; Hong, ; Wang et al, ). (6)Equity Joint Ventures (EJVs) (Nolan and Yeung, ; Boutellier and Ullman, ; Lee, ). (7)Public Research Institutes (Boutellier and Ullman, ; Wang et al, ). (8)Foreign R&D Centers (FR&D) (Lawrence, ; Gassmann et al, ; Un and Cuervo‐Cazurra, ). …”
Section: Case Applicationmentioning
confidence: 99%
“…(1) State-Owned Enterprises (SOEs) (White, 2000;Jiang et al, 2001;Nolan and Yeung, 2001;Wang et al, 2009). (2) High-tech Small-to-Medium Enterprises (SMEs) (Jiang et al, 2001;Boutellier and Ullman, 2007;Wang et al, 2009).…”
Section: Resource Alternativesmentioning
confidence: 99%